Sumitomo Chemcl (OTCMKTS:SOMMY) and ASP Isotopes (NASDAQ:ASPI) Critical Survey

Sumitomo Chemcl (OTCMKTS:SOMMY) and ASP Isotopes (NASDAQ:ASPI) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Profitability

This table compares Sumitomo Chemcl and ASP Isotopes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sumitomo Chemcl	2.65%	5.16%	1.80%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Institutional and Insider Ownership

16.8% of ASP Isotopes shares are owned by institutional investors. 14.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility and Risk

Sumitomo Chemcl has a beta of 0.31, meaning that its share price is 69% less volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.42, meaning that its share price is 242% more volatile than the S&P 500.

Valuation & Earnings

This table compares Sumitomo Chemcl and ASP Isotopes”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sumitomo Chemcl	$15.47 billion	0.34	$402.25 million	$1.24	12.93
ASP Isotopes	$23.85 million	33.52	-$175.09 million	($2.08)	-3.05

Sumitomo Chemcl has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Sumitomo Chemcl, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings for Sumitomo Chemcl and ASP Isotopes, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sumitomo Chemcl	0	1	0	0	2.00
ASP Isotopes	1	0	2	0	2.33

ASP Isotopes has a consensus target price of $13.00, suggesting a potential upside of 104.72%. Given ASP Isotopes’ stronger consensus rating and higher possible upside, analysts clearly believe ASP Isotopes is more favorable than Sumitomo Chemcl.

About Sumitomo Chemcl

Sumitomo Chemical Company, Limited engages in Chemicals & Plastics, energy and functional materials, IT-related chemicals, health and crop sciences, pharmaceuticals, and other businesses worldwide. Its Essential Chemicals & Plastics segment offers synthetic resins, such as polyethylene, polypropylene, and polymethyl methacrylate resins; raw materials for synthetic fibers; and various industrial chemicals. The company's Energy & Functional Materials segment provides alumina and aluminum products used for energy products; resorcinol for tires, wood adhesives, flame retardants, and ultraviolet ray absorbants; polymer additives and rubber chemicals; synthetic rubber for tires, shoes, construction materials, and other applications; and engineering plastics and lithium-ion secondary battery materials for use in electronic components and next-generation vehicles. Its IT-Related Chemicals segment provides polarizing films, touch screen sensor panels, and color resists and polymer OLED for LC and OLED displays; photoresists and high-purity chemicals for the semiconductor manufacturing process; and compound semiconductor materials for antenna switches and other components of communication terminal equipment. The company's Health & Crop Sciences segment offers crop protection chemicals, fertilizers, feed additives, and household insecticides; active pharmaceutical ingredients and intermediates; and products to control infectious diseases. Its Pharmaceuticals segment provides prescription and diagnostic pharmaceuticals. The company's Others segment supplies electric power and steam; designs, constructs, and supervises chemical plants; provides transportation and warehousing services; and conducts physical property and environmental analysis. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.